^
    BIOMARKER:

    ALK fusion

    i
    Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor




    Show legend

    Include preclinical:
    Non Small Cell Lung Cancer
    Melanoma
    Lung Non-Squamous Non-Small Cell Cancer
    Lung Adenocarcinoma
    Sarcoma
    Glioma
    Triple Negative Breast Cancer
    Colorectal Adenocarcinoma
    T Cell Non-Hodgkin Lymphoma
    Lung Cancer
    crizotinib
    alectinib
    entrectinib
    ALK inhibitor
    brigatinib
    lorlatinib
    ceritinib
    U3-1402
    anlotinib
    bevacizumab + alectinib
    pemetrexed
    gilteritinib